Type 2 diabetes in adults management

Other contextual questions included the evidence for screening specific populations; the clinical benefits and harms of early treatment of patients with IGT, IFG and type 2 diabetes; the effective risk assessment scores, diagnostic tests for detecting diabetes and the process and outcome performance...

Descripción completa

Detalles Bibliográficos
Autor principal: Internal Clinical Guidelines Team (author)
Autor Corporativo: Internal Clinical Guidelines Team, author, issuing body (author)
Formato: Seriada digital
Idioma:Inglés
Publicado: London : National Institute for Health and Care Excellence 2015.
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820430106719
Descripción
Sumario:Other contextual questions included the evidence for screening specific populations; the clinical benefits and harms of early treatment of patients with IGT, IFG and type 2 diabetes; the effective risk assessment scores, diagnostic tests for detecting diabetes and the process and outcome performance measures, or indicators that are identified in the literature to measure and monitor the impact of [...] Similarly to the ADA, the CDA has recommended the A1c test for diagnosing type 2 diabetes.43,52 However, the ADA recommends that the A1c test be used to screen for diabetes and/or assess the risk of future diabetes where appropriate, provided the A1c test is administered according to the National Glycohemoglobin Standardized Program (NGSP) and traceable to the Diabetes Control and Complications Tr [...] The outcomes of harms associated with diabetes screening resulted in the rankings presented in Table 1. The GRADE process was also used to assess risk of bias for individual studies addressing Key Questions 1 and 2. This was then used with the summary of findings to assess the overall quality of the evidence. [...] The authors conclude that it is unlikely that the early identification of diabetes was the explanation for a few deaths identified as diabetes related (8%) in this population cohort; rather the screening process and information on CV disease may have heightened the awareness of practitioners and patients, thus resulting in greater attention to risk factor modification and management.78 The risk of [...] Inclusion of Modeling Studies The methods manual of the CTFPHC allows for the use modeling studies when there is insufficient evidence to answer some or all of the key questions.79 The Diabetes Screening Working Group reviewed the available evidence and determined that there was insufficient evidence to adequately answer components of the effectiveness question particularly ages to begin or end sc.
Publicado:Began with: 2015-
Descripción Física:1 online resource
Frecuencia de Publicación:annual